ICD-10 Classifications The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes. Because Plaquenil does not have its own specific category, clinicians should use Z79.899—Other Long Term (Current) Drug Therapy.
Here’s the coding for a patient taking Plaquenil for RA: 1. Report M06.08 for RA, other, or M06.9 for RA, unspecified (always report the systemic disease state first). 2. Report Z79.899 for Plaquenil use for RA.
The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes.
ICD-10 code Z51. 81 for Encounter for therapeutic drug level monitoring is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Even though ICD-10-CM does not provide a specific code for immunosuppressants, Z79. 899 is used to identify the immunosuppressant therapy.
2022 ICD-10-CM Diagnosis Code Z79. 899: Other long term (current) drug therapy.
899 or Z79. 891 depending on the patient's medication regimen. That said, it was always a supporting diagnosis, never primary.
Z92. 25 - Personal history of immunosuppression therapy. ICD-10-CM.
ICD-10-CM Code for Immunodeficiency, unspecified D84. 9.
The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes. Because Plaquenil does not have its own specific category, clinicians should use Z79. 899—Other Long Term (Current) Drug Therapy.
For the monitoring of patients on methadone maintenance and chronic pain patients with opioid dependence use diagnosis code Z79. 891, suspected of abusing other illicit drugs, use diagnosis code Z79. 899.
If the type 2 diabetic patient uses insulin or oral hypoglycemic medication, the medications can be coded as Z79. 4 or Z79. 84, respectively. If the diabetic patient takes both oral medication and insulin, it is only necessary to code the insulin usage.
What is Hydroxychloroquine (Plaquenil®)? Hydroxychloroquine is used in the treatment of arthritis to help relieve inflammation, swelling, stiffness, and joint pain and also to help control the symptoms of lupus erythematosus (lupus; SLE). A common brand name for hydroxychloroquine is Plaquenil®.
CPT® 80307, Under Presumptive Drug Class Screening Procedures. The Current Procedural Terminology (CPT®) code 80307 as maintained by American Medical Association, is a medical procedural code under the range - Presumptive Drug Class Screening Procedures.
ICD-10 Code for Rheumatoid arthritis, unspecified- M06. 9- Codify by AAPC.
When coding for these individuals, it is important to understand the mechanism in place. The patient is taking a long-term medication for a specific systemic condition, such as rheumatoid arthritis (RA), so the first step is coding for that. This is where communication with other physicians is paramount. You and the patient’s other providers need to remain consistent with the ICD-10 code used to describe the condition for which the patient is being treated. Once you know the primary systemic condition, you can code the medication use and any adverse effects that require further attention.
If maculopathy is present, report the adverse effect of the hydroxychloroquine as well: T37.2x5A: Adverse effect of anti-malarials and drugs acting on other blood protozoa, initial encounter. T37.2x5D: Adverse effect of anti-malarials and drugs acting on other blood protozoa, subsequent encounter.
The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes. Because Plaquenil does not have its own specific category, clinicians should use Z79.899—Other Long Term (Current) Drug Therapy.
P atients taking Plaquenil (hydroxychloroquine, Sanofi-Aventis) on a long-term basis may leave you scratching your head when it comes to coding the patient encounters. Although coding for long-term medications is not a difficult process, it often involves communicating with other physicians or specialists to obtain accurate information.